Two high-profile bills to rein in soaring health care bills won their first green lights from state Senate gatekeepers.
One, Senate Bill 271, sets price caps on costly, but widely prescribed, medications.
The other, Senate Bill 669, cracks down on pharmacy benefit managers, the middlemen blamed by many, including former Attorney General Jason Miyares, for the faster-than-inflation rises in medication prices.
Read the full story in the Richmond Time-Dispatch.
